Compare Chubb Ltd (CB) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chubb Ltd vs Inovio Pharmaceuticals Inc — how do they compare? Chubb Ltd trades at $347 (market cap $134.37B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M). The key difference: Chubb Ltd is far larger — about 1765.9× Inovio Pharmaceuticals Inc's market cap, and Chubb Ltd pays a 1.17% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CB | INO | |
|---|---|---|
Market Cap | $134.37B | $76.09M |
Sector | Financials | Health |
52-Week High | $363.50 | $2.87 |
52-Week Low | $268.20 | $0.66 |
Enterprise Value | $155.22B | $47.10M |
Dividend Yield | 1.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Chubb (CB) trades at $350.31, down 1.05% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals, with Q2 2026 EPS of $7.26 beating estimates, revenue growth to $59.78B in 2025, and a net income margin of 17.96%. Recent news highlights leadership appointments and positive earnings coverage.
The outlook is positive, supported by consistent earnings beats, a 52.38% analyst buy rating, and a consensus price target of $366.83. Risks include macroeconomic sensitivity and competitive pressures in insurance. The stock presents a value opportunity with a P/E of 12.41 and robust cash flow trends.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Chubb Ltd
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Read more on CB →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
